Autologous Immune Cell Therapy

· Shanghai AbelZeta Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Autologous Immune Cell Therapy, covering 2013-12-23 to 2017-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC [Phase 1, Phase 2]